Month: October 2026

Oct 09 2026

Uncategorized

Click claims FDA okay for first-in-class schizophrenia DTx

by Clinical Editor

No Comments

Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia – a digital therapeutic (DTx) called Motivista. Formerly known as CT-155, Motivista …

Oct 08 2026

Uncategorized

Muscarinic Treatment for Schizophrenia: A Presynaptic Answer to a Presynaptic Problem – Psychiatric Times

by Clinical Editor

No Comments

Muscarinic Treatment for Schizophrenia: A Presynaptic Answer to a Presynaptic Problem  Psychiatric Times

Oct 07 2026

Uncategorized

Meet Motivista: Click Therapeutics debuts first-of-its-kind schizophrenia digital therapeutic – Fierce Biotech

by Clinical Editor

No Comments

Meet Motivista: Click Therapeutics debuts first-of-its-kind schizophrenia digital therapeutic  Fierce Biotech

Oct 04 2026

Uncategorized

Recovery from Schizophrenia

by Clinical Editor

No Comments

The possibilities of recovery and the search for treatments are the subjects of an enormous amount of research, and a wide range of opinion.

Oct 04 2026

Uncategorized

Understanding Schizophrenia through ‘Brain Function’ — Capturing Symptoms through Brain Function and Connecting Them to Occupational Therapy —

by Clinical Editor

No Comments

In occupational therapy for schizophrenia, it is important not only to look at “What can this person not do?” but also to consider “Why is that activity becoming difficult?” Schizophrenia...

Oct 03 2026

Uncategorized

Schizophrenia Made Me a Better Person – Psychology Today

by Clinical Editor

No Comments

Schizophrenia Made Me a Better Person  Psychology Today

Oct 03 2026

Uncategorized

Schizophrenia Made Me a Better Person

by Clinical Editor

No Comments

I was recently recording a podcast with a producer who asked me the following question: Has schizophrenia changed who you are as a person? I was so surprised by his...

Oct 02 2026

Uncategorized

VA’s New Antidepressant Rules; App Aids Schizophrenia; Diet and Depression – MedPage Today

by Clinical Editor

No Comments

VA’s New Antidepressant Rules; App Aids Schizophrenia; Diet and Depression  MedPage Today

Oct 02 2026

Uncategorized

Alzheimer’s risk gene APOE4 may have a reversible weakness

by Clinical Editor

No Comments

The Alzheimer’s risk gene APOE4 may actively damage brain blood vessels and sabotage the cellular systems that remove harmful proteins. Researchers were able to reverse some of these effects in...

Oct 01 2026

Uncategorized

Nursing home asks court to block Five-Star changes tied to schizophrenia audits – mcknights.com

by Clinical Editor

No Comments

Nursing home asks court to block Five-Star changes tied to schizophrenia audits  mcknights.com